1986
DOI: 10.1016/0020-7292(86)90015-9
|View full text |Cite
|
Sign up to set email alerts
|

Management of pregnancy‐induced hypertension with pindolol‐comparative study with methyldopa

Abstract: Thirty-two consecutive women with pregnancy-induced hypertension of early onset were randomly allocated to treatment with pindolol or methyldopa. There was no difference between the groups in regard to the average time of delivery (36.33 vs. 36.6 weeks) and weight of the newborn (2850 vs. 2870 g). A significant drop in systolic (P less than 0.005) and diastolic (P less than 0.05) blood pressure was observed in the group of patients treated with pindolol as compared with the methyldopa group. In the pindolol gr… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
5
2

Year Published

1992
1992
2018
2018

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 28 publications
(8 citation statements)
references
References 10 publications
1
5
2
Order By: Relevance
“…The present results disagree with published clinical reports which have demonstrated that a-methyldopa does not cause any effective fetal involvement [5,7,8], This is probably due to the presence of several circulating hor mones and enzymes during pregnancy, which may control the functioning of the umbilical-placental circulation. Particularly important among these hormones are ste roids which have a marked vasodilating effect [9], In addition, a predominant central effect of a-methyldopa has been demonstrated in both animals and humans, act ing on presynaptic ai-adrenergic receptors and causing a reduction of peripheral sympathetic tonus.…”
Section: Resultscontrasting
confidence: 57%
“…The present results disagree with published clinical reports which have demonstrated that a-methyldopa does not cause any effective fetal involvement [5,7,8], This is probably due to the presence of several circulating hor mones and enzymes during pregnancy, which may control the functioning of the umbilical-placental circulation. Particularly important among these hormones are ste roids which have a marked vasodilating effect [9], In addition, a predominant central effect of a-methyldopa has been demonstrated in both animals and humans, act ing on presynaptic ai-adrenergic receptors and causing a reduction of peripheral sympathetic tonus.…”
Section: Resultscontrasting
confidence: 57%
“…The present demonstration of the vasconstrictive ef fect of a-methyldopa contrasts with the conclusions of other studies which have shown that a-methyldopa does not effectively impair the fetus [6,9,10], This difference may be due to circulatory hormones and enzymes present during pregnancy which may modulate the umbilicoplacental circulation. Particularly important are the steroids, which have a marked vasodilating effect on human umbil ical artery [11].…”
Section: Resultscontrasting
confidence: 56%
“…This medication is typically administered to patients with heart failures, renal failures, and diabetes [2]. Furthermore, it is one of the few antihypertensives indicated in pregnancy-induced hypertension [2,3]. A structural feature of the drug is an amino acid skeleton with a catechol group as found in DOPA, an anti-Parkinsonism medication.…”
Section: Introductionmentioning
confidence: 99%